| Authors: |
Thatikonda V; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Global Computational Biology and Digital Sciences, Boehringer Ingelheim RCV GmbH, Vienna, Austria., Islam SMA; Department of Cellular and Molecular Medicine and Department of Bioengineering, Moores Cancer Center, UC San Diego, La Jolla, CA, USA., Autry RJ; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Jones BC; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.; Pediatric Glioma Research Group, DKFZ, Heidelberg, Germany., Gröbner SN; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Warsow G; Omics IT and Data Management Core Facility (W610), DKFZ, Heidelberg, Germany., Hutter B; German Cancer Consortium (DKTK), Heidelberg, Germany.; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) Heidelberg, DKFZ, Heidelberg, Germany.; Division of Applied Bioinformatics, DKFZ, Heidelberg, Germany., Huebschmann D; German Cancer Consortium (DKTK), Heidelberg, Germany.; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) Heidelberg, DKFZ, Heidelberg, Germany.; Pattern Recognition and Digital Medicine, Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany., Fröhling S; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Translational Medical Oncology, NCT Heidelberg and DKFZ, Heidelberg, Germany., Kool M; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Blattner-Johnson M; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Pediatric Glioma Research Group, DKFZ, Heidelberg, Germany., Jones DTW; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Pediatric Glioma Research Group, DKFZ, Heidelberg, Germany., Alexandrov LB; Department of Cellular and Molecular Medicine and Department of Bioengineering, Moores Cancer Center, UC San Diego, La Jolla, CA, USA., Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany. s.pfister@kitz-heidelberg.de.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. s.pfister@kitz-heidelberg.de.; German Cancer Consortium (DKTK), Heidelberg, Germany. s.pfister@kitz-heidelberg.de.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany. s.pfister@kitz-heidelberg.de., Jäger N; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany. n.jaeger@kitz-heidelberg.de.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. n.jaeger@kitz-heidelberg.de.; German Cancer Consortium (DKTK), Heidelberg, Germany. n.jaeger@kitz-heidelberg.de. |
